Malick jeffrey (26 résultats)

paperback. Etat : Good. volume 20, previous owner's ink stamp in front, hardcover edition Good hardcover with some shelfwear; may have previous owner's name inside. Standard-sized.

Hardcover. Etat : Near Fine. Etat de la jaquette : Fine. An excellent copy with dustcover. Blue paper-covered boards, gilt spine lettering, 9 1/2 x 6 1/4 inches, 222 pp., index. Book near fine (inscription to previous owner on front free endpaper; one page with a small amount of yellow highlighting). Dustcover fine. (K031).…

Hardcover. Etat : Good. 8vo. Hardcover. No dj, as issued. Good condition. Ex-lib copy w/ markings to opening pgs, text-block edges stamped, rear pocket & spine label; contents clean, binding firm. xi, 296 p., illus.

Etat : New. Satisfaction Guaranteed or your money back.

Etat : Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.…

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New. In English.

Etat : New. In English.

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New. Num Pages: 448 pages, biography. BIC Classification: MQP. Category: (G) General (US: Trade). Dimension: 235 x 155 x 24. Weight in Grams: 712. . 2011. Paperback. . . . .

Etat : New. pp. 468.

Etat : New. Series: Contemporary Biomedicine. Num Pages: 448 pages, biography. BIC Classification: MBGR; MMG. Category: (P) Professional & Vocational. Dimension: 234 x 156 x 25. Weight in Grams: 829. . 1987. Hardback. . . . .

Gebunden. Etat : New. Overview.- Drug Discovery and Development: Reflections and Projections.- 1. Introduction.- 2. Drug Discovery.- 2.1. General Issues.- 2.2. Compound Sources.- 2.3. Goal Identification.- 3. The Project Team.- 4. The Flow Chart.- 4.1. The Primary Screen.- 4.2. .

Etat : New. Overview.- Drug Discovery and Development: Reflections and Projections.- 1. Introduction.- 2. Drug Discovery.- 2.1. General Issues.- 2.2. Compound Sources.- 2.3. Goal Identification.- 3. The Project Team.- 4. The Flow Chart.- 4.1. The Primary Screen.- 4.2. .

Etat : New. pp. 468.

Etat : New. Num Pages: 448 pages, biography. BIC Classification: MQP. Category: (G) General (US: Trade). Dimension: 235 x 155 x 24. Weight in Grams: 712. . 2011. Paperback. . . . . Books ship from the US and Ireland.

Etat : New. Series: Contemporary Biomedicine. Num Pages: 448 pages, biography. BIC Classification: MBGR; MMG. Category: (P) Professional & Vocational. Dimension: 234 x 156 x 25. Weight in Grams: 829. . 1987. Hardback. . . . . Books ship from the US and Ireland.

Buch. Etat : Neu. Neuware - The conceptual process of drug discovery is one that is often the result of an identified need in a defined disease area. This need represents a mandate from the marketing department of a phar maceutical company or a breakthrough at the research level that has agreed applicability in response to a valid therapeutic demand. Although the intelligent design and development of new thera peutic entities, as evidenced by Sir James Black's H -receptor an 2 tagonist cimetidine (Tagamet), is intellectually satisfying, many novel drugs arise from serendipity, from the chance observation of the research scientist or the clinician, that a compound has unex pected actions of use for the treatment of human disease states. Drugs that have been identified by this route include the antipsy chotic chlorpromazine and the putative anxiolytic buspirone. The events surrounding the process of drug discovery and de velopment are the theme of the present volume, which attempts to present, in a logical and lucid manner, the complexity of a process that is often naively assumed to represent nothing more than the identification of a new compound and its rapid introduction into humans, free of such complications as efficacy, selectivity, safety, bioavailability, toxicity, and need.…

in-8, hardcover, 296p. Good condition. ISBN 10 : 0824716876ISBN 13 : 9780824716875.

Etat : New. Print on Demand pp. 468 52:B&W 6.14 x 9.21in or 234 x 156mm (Royal 8vo) Case Laminate on White w/Gloss Lam.

Etat : New. PRINT ON DEMAND pp. 468.

Etat : New. Print on Demand pp. 468 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam.

Etat : New. PRINT ON DEMAND pp. 468.

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The conceptual process of drug discovery is one that is often the result of an identified need in a defined disease area. This need represents a mandate from the marketing department of a phar maceutical company or a breakthrough at the research level that has agreed applicability in response to a valid therapeutic demand. Although the intelligent design and development of new thera peutic entities, as evidenced by Sir James Black's H -receptor an 2 tagonist cimetidine (Tagamet), is intellectually satisfying, many novel drugs arise from serendipity, from the chance observation of the research scientist or the clinician, that a compound has unex pected actions of use for the treatment of human disease states. Drugs that have been identified by this route include the antipsy chotic chlorpromazine and the putative anxiolytic buspirone. The events surrounding the process of drug discovery and de velopment are the theme of the present volume, which attempts to present, in a logical and lucid manner, the complexity of a process that is often naively assumed to represent nothing more than the identification of a new compound and its rapid introduction into humans, free of such complications as efficacy, selectivity, safety, bioavailability, toxicity, and need.…